tirzepatide microdosing with Mounjaro KwikPens | Scott Isaacs, MD, FACP, FACE posted on the topic Microdosing Tirzepatide Chart: A Weekly

Elie Levine, director of plastic surgery at Plastic Surgery & Dermatology of NYC PLLC, told Heathline

The practical takeaway here is that cagrilintide represents a genuinely new approach, not just a variation on existing GLP-1 medications

In Phase 2 trial settings, participants have shown gradual but meaningful reductions in body weight over several months, alongside improvements in blood glucose control, blood pressure, and metabolic markers

Should GLP-1 therapy be stopped if skin symptoms change

Nencioni A, Caffa I, Cortellino S, Longo VD

These metabolic benefits were dose-dependent and correlated with weight loss magnitude